Costs of diabetes - A methodological analysis of the literature

被引:43
作者
Pagano, E [1 ]
Brunetti, M [1 ]
Tediosi, F [1 ]
Garattini, L [1 ]
机构
[1] Mario Negri Inst Pharmacol Res, CESAV, Ctr Hlth Econ, I-24020 Ranica, BG, Italy
关键词
D O I
10.2165/00019053-199915060-00006
中图分类号
F [经济];
学科分类号
02 ;
摘要
Objective: To review studies on the costs of diabetes and its complications through a scheme designed specifically for assessing the quality of cost-of-illness (COI) studies. Design and Setting: The methodology of COI studies in diabetes was analysed in order to assess the significance of quantitative results. The scheme adopted 7 items identified as the main points for discussing the methodological choices governing the results. We also used a checklist based on questions related to the 7 items. Main outcome measures and results: The answers showed that many studies appear not to give technical details, so it is hard to understand the method. Methodological choices varied widely between the studies. This is probably due to the lack of consensus on the methodology of COI studies. Based on the findings of this review, we suggest also some specific points that could help produce more reliable results on the costs of diabetes. Conclusions: Clearly, a general consensus on COI studies is still remote, making the value of any comparison of results questionable.
引用
收藏
页码:583 / 595
页数:13
相关论文
共 83 条
[1]  
*ADA, 1993, DIR IND COSTS DIAB U
[2]   Sensitivity analysis in health economic and pharmacoeconomic studies - An appraisal of the literature [J].
Agro, KE ;
Bradley, CA ;
Mittmann, N ;
Iskedjian, M ;
Ilersich, AL ;
Einarson, TR .
PHARMACOECONOMICS, 1997, 11 (01) :75-88
[3]   DIABETES CARE IN A UK HEALTH REGION - ACTIVITY, FACILITIES AND COSTS [J].
ALEXANDER, WD .
DIABETIC MEDICINE, 1988, 5 (06) :577-581
[4]   COST OF ILLNESS STUDIES IN HEALTH-CARE - A COMPARISON OF 2 CASES [J].
AMENT, A ;
EVERS, S .
HEALTH POLICY, 1993, 26 (01) :29-42
[5]  
Australia Commonwealth Department of Human Services and Health, 1995, GUID PHARM IND PREP
[6]  
BENTON GS, 1985, SURG GYNECOL OBSTET, V161, P523
[7]   Economic evaluation in healthcare - A brief history and future directions [J].
Blumenschein, K ;
Johannesson, M .
PHARMACOECONOMICS, 1996, 10 (02) :114-122
[8]  
BOOTMAN JL, 1991, PRINCIPLES PHARMACOE
[9]   IS SCREENING AND INTERVENTION FOR MICROALBUMINURIA WORTHWHILE IN PATIENTS WITH INSULIN-DEPENDENT DIABETES [J].
BORCHJOHNSEN, K ;
WENZEL, H ;
VIBERTI, GC ;
MOGENSEN, CE .
BRITISH MEDICAL JOURNAL, 1993, 306 (6894) :1722-1723
[10]  
BRANSOME ED, 1992, DIABETES CARE, V15, P1